RVTY Revvity, Inc.
Healthcare$96.83-0.12%ClosedMarket Cap: $10.80B
As of 2026-05-26
Valuation
P/E (TTM)
40.61
PEG
—
P/B
1.51
P/S
3.73
EV/EBITDA
17.19
DCF Value
$112.03
FCF Yield
4.6%
Div Yield
0.3%
Margins & Returns
Gross Margin
51.4%
Operating Margin
12.4%
Net Margin
8.3%
ROE
3.3%
ROA
2.0%
ROIC
2.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $711.1M | 54.5% | $75.9M | $40.7M | $— | $0.07 |
| Q4 null | $772.1M | 43.8% | $111.7M | $98.4M | $— | $0.07 |
| FY null | $2.86B | 53.1% | $356.6M | $241.7M | $— | $0.28 |
| Q3 null | $698.9M | 53.6% | $81.9M | $46.7M | $— | $0.07 |
| Q2 null | $720.3M | 54.5% | $90.8M | $55.2M | $— | $0.07 |
| Q1 null | $664.8M | 56.5% | $72.2M | $42.2M | $— | $0.07 |
| Q4 null | $729.4M | 49.3% | $132.3M | $95.0M | $— | $0.07 |
| FY null | $2.76B | 48.0% | $410.5M | $295.8M | $— | $0.28 |
| Q3 null | $684.0M | 56.3% | $102.6M | $94.0M | $— | $0.07 |
| Q2 null | $691.7M | 55.7% | $101.5M | $79.1M | $— | $0.07 |
| Q1 null | $649.9M | 54.6% | $74.1M | $27.7M | $— | $0.07 |
| Q4 2023 | $695.9M | 42.2% | $99.4M | $102.7M | $0.83 | $0.07 |